Evidence map›Paper›PMID 42643723›Full record

ArticleIntractable & rare diseases research2026

Fulminant myocarditis and sudden death associated with thymoma-related autoimmunity.

Ying Liu, Xue Yin, Baitong Wang, Yuqing Zhao, Xianglin Chu, Liewen Pang, Chongbo Zhao, Jian Li, Yiming Wang, Sushan Luo

Abstract readLetter
In one paragraph

Article in Intractable & rare diseases research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ying LiuDepartment of Neurology, the Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Xue YinDepartment of Neurology, Daqing Longnan Hospital, Daqing, Heilongjiang, China.
Baitong WangDepartment of Encephalopathy, the Affiliated Hospital to Changchun University of Chinese Medicine, Jilin, Changchun, China.
Yuqing ZhaoDepartment of Digestive Disorders, Huashan Hospital, Fudan University, Shanghai, China.
Xianglin ChuDepartment of Cardiothoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Liewen PangDepartment of Cardiothoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Chongbo ZhaoHuashan Rare Disease Center and Department of Neurology, Huashan Hospital, Shanghai Medical College, National Center for Neurological Disorders, Fudan University, Shanghai, China.
Jian LiDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai, China.
Yiming WangDepartment of Cardiology, Huashan Hospital, Fudan University, Shanghai, China.
Sushan LuoHuashan Rare Disease Center and Department of Neurology, Huashan Hospital, Shanghai Medical College, National Center for Neurological Disorders, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fulminant myocarditis (FM) is a severe, rapidly progressive and life-threatening condition of myocarditis associated with infectious or autoimmune etiologies. Here, we present three patients with an invasive thymoma who had FM, which eventually led to sudden death. The most frequent clinical presentations at onset include palpitations, orthopnea, and acute worsening of myasthenia gravis (MG). Highly elevated myocardial biomarkers and positive autoantibodies against cardiac muscle, skeletal muscle, and neuromuscular junctions were detected in serum. The electrocardiograph (ECG) findings progressed to life-threatening ventricular arrhythmias. Although high-dose methylprednisolone or intravenous immunoglobulin was administered along with advanced respiratory support, profound hemodynamic collapse rapidly occurred, and these patients eventually died within days. This case series underscores the importance of rapid recognition of FM associated with thymoma and early aggressive supportive and immunomodulatory interventions, including consideration of mechanical circulatory support when clinically indicated.

Indexed as

autoantibodyfulminant myocarditisinvasive thymomasudden cardiac death

Identifiers

PMID42643723
PMCPMC13504678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.